StonvexLoading…
StonvexStonvexStonvexCore line items from CVX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $47.56B | $184.43B | $138.65B | $90.48B |
Operating Income | $3.95B | $19.74B | $15.14B | $9.73B |
Net Income | $2.21B | $12.30B | $9.53B | $5.99B |
EPS (Diluted) | $1.11 | $6.63 | $5.27 | $3.45 |
Total Assets | $329.55B | $324.01B | $326.50B | $250.82B |
Total Liabilities | $140.18B | $131.84B | $130.90B | $103.56B |
Cash & Equivalents | $6.32B | $7.29B | $8.78B | $5.38B |
Free Cash Flow OCF − CapEx | $-1.55B | $16.59B | $11.07B | $6.13B |
Shares Outstanding | 1.99B | 1.86B | 1.81B | 1.74B |